Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,07 USD | -6,14% | -17,69% | +20,73% |
15/04 | Faron Pharmaceuticals herbenoemt voormalig financieel directeur op interim-basis | AN |
03/04 | Top Middag Decliners | MT |
Omzet 2024 * | 155 mln. 145 mln. | Omzet 2025 * | 169 mln. 158 mln. | Marktkapitalisatie | 106 mln. 98,75 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -142 mln. -133 mln. | Nettowinst (verlies) 2025 * | -102 mln. -95,31 mln. | EV/omzet 2024 * | 0,68 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,62 x |
K/w-verhouding 2024 * |
-0,76
x | K/w-verhouding 2025 * |
-1,07
x | Werknemers | 486 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 93,63% |
Recentste transcriptie over FibroGen, Inc.
1 dag | -6,14% | ||
1 week | -17,69% | ||
Lopende maand | -54,47% | ||
1 maand | -58,53% | ||
3 maanden | +19,89% | ||
6 maanden | +111,00% | ||
Lopend jaar | +20,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thane Wettig
CEO | Chief Executive Officer | 59 | 22-06-20 |
Juan Graham
DFI | Director of Finance/CFO | 48 | 07-09-21 |
James Schoeneck
CHM | Chairman | 66 | 01-04-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Edwards
BRD | Director/Board Member | 64 | 28-10-15 |
Director/Board Member | 59 | 06-08-15 | |
May Kin Ho
BRD | Director/Board Member | 71 | 06-12-18 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
3.83% | 1 M€ | 0,00% | - | |
0.13% | 0 M€ | 0,00% | - | |
0.12% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 1,07 | -6,14% | 1 349 229 |
22-04-24 | 1,14 | -0,87% | 803 876 |
19-04-24 | 1,15 | -1,71% | 1 312 940 |
18-04-24 | 1,17 | -7,87% | 1 278 178 |
17-04-24 | 1,27 | -2,31% | 1 031 441 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,73% | 106 mln. | |
+3,13% | 43,43 mld. | |
+48,83% | 41,69 mld. | |
+8,49% | 41,31 mld. | |
-10,82% | 27,14 mld. | |
+8,26% | 25,28 mld. | |
-23,69% | 18,47 mld. | |
+1,58% | 12,33 mld. | |
+32,83% | 12,59 mld. | |
+6,63% | 11,03 mld. |